Kent J Riley Selected Research

Cetuximab (Erbitux)

2/2008	Molecular targeting and treatment of composite EGFR and EGFRvIII-positive gliomas using boronated monoclonal antibodies.
2/2007	Molecular targeting and treatment of an epidermal growth factor receptor-positive glioma using boronated cetuximab.
11/2004	Neutron capture therapy of epidermal growth factor (+) gliomas using boronated cetuximab (IMC-C225) as a delivery agent.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kent J Riley Research Topics

Disease

10	Glioma (Gliomas) 12/2015 - 11/2004
10	Neoplasms (Cancer) 12/2015 - 03/2003
7	Brain Neoplasms (Brain Tumor) 12/2015 - 08/2002
1	Head and Neck Neoplasms (Head and Neck Cancer) 08/2012
1	Glioblastoma (Glioblastoma Multiforme) 10/2003
1	Body Weight (Weight, Body) 08/2002

Drug/Important Bio-Agent (IBA)

7	BoronIBA 08/2012 - 10/2003
4	Monoclonal AntibodiesIBA 02/2008 - 11/2004
3	Epidermal Growth Factor (EGF)IBA 12/2009 - 11/2004
3	Cetuximab (Erbitux)FDA Link 02/2008 - 11/2004
2	ThymidineIBA 12/2015 - 11/2008
2	thymidine kinase 1IBA 12/2015 - 11/2008
2	ErbB Receptors (EGF Receptor)IBA 02/2008 - 02/2007
2	epidermal growth factor receptor VIIIIBA 02/2008 - 06/2006
1	EnzymesIBA 12/2015
1	SodiumIBA 12/2011
1	Carboplatin (JM8)FDA LinkGeneric 12/2011
1	Pharmaceutical PreparationsIBA 12/2011
1	PorphyrinsIBA 06/2011
1	Dendrimers (Dendrons)IBA 12/2009
1	A 7 (A-7)IBA 12/2009
1	4-boronophenylalanine-fructoseIBA 08/2002
1	FructoseIBA 08/2002

Therapy/Procedure

8	Boron Neutron Capture Therapy 08/2012 - 10/2003
6	Neutron Capture Therapy 12/2015 - 03/2003
2	Therapeutics 02/2008 - 10/2003
1	Injections 11/2008
1	Nuclear Reactors 02/2008